AstraZeneca Will Negotiate With Medicare On Price For Diabetes Drug
Drugmaker AstraZeneca tells Politico that it plans to participate in negotiations with CMS over the price Medicare pays for Farxiga, a drug used to treat type 2 diabetes, as well as heart failure and chronic kidney disease. In other news, a new study quantifies the big impact of the "pink tax" on womens' health care costs.